Category Traditional and Indigenous Knowledge

UN Biodiversity Convention Agrees On Precautionary Approach To Synthetic Biology

SHARM El-SHEIKH, Egypt -- While the world has been taken by surprise after a Chinese researcher declared he had genetically modified twin babies, and critics are rising from all parts, the Convention on Biological Diversity adopted a decision on synthetic biology today at the close of its biennial meeting. The decision which calls for a precautionary approach was hailed by civil society groups which were calling for a moratorium preventing gene drive organisms to be released in the wild.

Shared Indigenous Knowledge And Benefit-Sharing Needs Particular Attention, Panel Tells CBD

SHARM El-SHEIKH, Egypt -- Traditional knowledge associated with genetic resources held by indigenous and local communities is often not confined to one group or one specific geographical location. Displacement whether cultural or forced, political redesigning of borders, and exchanges with other communities have all contributed to the dispersion of that knowledge. This shared knowledge poses an issue in the context of benefit-sharing of commercial benefits on inventions derived from this knowledge. A side event on the side of the biennial meeting of the UN Convention on Biological Diversity looked at how to address shared traditional knowledge.

Gene Editing Divides UN Biodiversity Convention Members On Synthetic Biology Evaluation

SHARM EL-SHEIKH, Egypt -- After informal closed consultations, a draft decision was issued yesterday on how the UN Convention on Biological Diversity should address potential impacts of synthetic biology, during the biennial conference of the parties taking place this week. The issue of the release of gene drive organisms into the environment was a contentious issue as civil society had been lobbying for a moratorium preventing the release into the wild of those organisms able to wipe out entire species. This morning consensus was still eluding delegates, particularly over the singling out of gene editing in the decision.

Panellists To CBD: Funds Needed To Save Biodiversity, Genetic Resources Not In Nagoya Protocol Should Be Included

SHARM-EL-SHEIKH, Egypt - The access and benefit sharing protocol of the UN Convention on Biological Diversity is based on bilateral agreements between providers and users of genetic resources. There are, however, many cases where genetic resources are dispersed, and difficult to attribute to only one location. The issue is being discussed at the biennial meeting of the CBD member states, in particular the possibility of a global multilateral benefit-sharing mechanism to address those genetic resources not yet covered by the protocol. A side event yesterday explored the possible conditions and needs for establishing such a mechanism, and called for urgent action.

Gene Editing: Fears Lead To Call For Moratorium At CBD, Discussions Ongoing

Gene editing techniques have opened the way to a new world of innovations. One of them is the potential eradication of malaria-carrying mosquitoes. What appears as a very attractive way to help with malaria eradication is denounced by civil society groups arguing that the technology is in its infancy. Wiping out entire species could have unforeseen environmental, health, and social consequences, they say. They are calling for a moratorium preventing the release of gene drive organisms in the wild. They also describe the gene drive mosquitoes as a Trojan horse, hiding broader interests of agricultural multinational corporations.

Convention On Biological Diversity Biennial Meeting Looks At How New Technologies Will Affect Its Objectives

Member countries of the UN Convention on Biological Diversity are meeting in Egypt for its biennial conference of the parties, and the conference of the parties of its protocol on access and benefit sharing, until the end of November. New technologies are high on the agenda of the meeting, such as synthetic biology and genetic sequence information of genetic resources, and how they will impact the convention's objectives. Delegates are also expected to discuss a potential global multilateral benefit-sharing mechanism, and criteria for international specialised instruments of access and benefit-sharing which could substitute the protocol's obligations in certain cases.

Global Biotech Industry Revisits Geneva, Seeks To Build Relationships To Help Shape Policies

A global association representing biotechnology industries last week made a second annual visit to Geneva's institutions to raise awareness of how the industry works, its needs, and how the association could participate better in policymaking. Dismissing fears of industry unduly influencing public policies, two representatives of the association sat down with Intellectual Property Watch's Catherine Saez to explain the importance of biotechnology in solving the problems of the world, and the need to raise awareness of the perspective of the biotechnology sector.

WIPO Members Look At Protection Of Country Names, GIs, Icons

A number of countries are voicing concerns about their country name being used by trademark applicants with no relation to the country, riding on the country's reputation or geographical relevance. They are also worried about their country name being used as an internet top-level domain name. Those are among the issues being discussed this week at the World Intellectual Property Organization committee on trademarks, along with questions on the protection of geographical indications, and of icons and typeface on the internet.

WHO Members Consider Possible Changes To Pandemic Influenza Framework

A hundred years ago, the influenza pandemic known as the “Spanish flu” infected one-third of the world population, and resulted in an estimated 50 million deaths. Last week, the World Health Organization held a consultation on possible changes to its 2011 agreement to prepare for the next pandemic influenza. Two major questions were on the table: whether to extend its agreement to seasonal influenza, and how to deal with pandemic influenza genetic information, which is increasingly used instead of biological samples of viruses.